VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RARE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RAREUltragenyx Pharmaceutical Inc.
$33.70$3.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRAREPrice History

RARE logoUltragenyx Pharmaceutical Inc. (RARE) Stock Price History

Historical prices from 2014 to 2026

$33.70+0.23  (+0.69%)close Jul 6
Returns
1M
+56.1%
3M
+47.4%
YTD
+42.8%
1Y
-14.9%
3Y
-9.5%
5Y
-18.1%
ATH$179.65Dec 2020-81.2%
ATL$18.29Mar 2026pre-split
Avg Vol (50D)1.7M/ day
52-Week Range$18.29 — $42.37
LowCurrent: $33.70High

Loading 10-year price history...

RARE Historical Performance

1 YearTotal Return
-14.9%
Price: -14.9%
3 YearsTotal Return
-26.0%
CAGR: -9.5%
Price: -26.0%
5 YearsTotal Return
-63.1%
CAGR: -18.1%
Price: -63.1%
YTD
+42.8%

RARE Annual Returns

Year-by-year price performance · 2014–2026

Best+221.1%2020
Worst-45.1%2022
Up years5/13
2014+3.9%
2015+141.8%
2016-31.0%
2017-33.7%
2018-11.8%
2019+2.4%
2020+221.1%
2021-38.4%
2022-45.1%
2023+5.1%
2024-12.7%
2025-44.1%
2026-0.9%
2014 annual price return
+3.9%
2015 annual price return
+141.8%
2016 annual price return
-31.0%
2017 annual price return
-33.7%
2018 annual price return
-11.8%
2019 annual price return
+2.4%
2020 annual price return
+221.1%
2021 annual price return
-38.4%
2022 annual price return
-45.1%
2023 annual price return
+5.1%
2024 annual price return
-12.7%
2025 annual price return
-44.1%
2026 annual price return
-0.9%
LessMore
Alpha vs S&P 500
1Y-42.5%
3Y-36.3%
5Y-32.6%

Price returns only.

Download Historical Data

3,125 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

RARE Stock Price Trajectory (2014–2026)

As of July 7, 2026, Ultragenyx Pharmaceutical Inc. (RARE) trades at $33.70, representing a -14.9% return over the past year. The stock has delivered a -63.1% total return over five years (-18.1% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $179.65 on December 24, 2020. From this peak, RARE has corrected -81.2%, currently trading 25% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers BMRN (+2.4% 1Y), SRPT (+10.7% 1Y), and IONS (+99.1% 1Y), RARE has underperformed the peer group average. Compare RARE vs BMRN →

RARE Historical Price Data · from 2014

Rows 1–50 of 3,125
Date Open High Low Close Volume Change %
2026-07-0633.4834.1932.9433.701.53M+0.69%
2026-07-0232.8733.5032.4833.471.21M+3.37%
2026-07-0133.1333.4932.3432.382.31M-3.02%
2026-06-3031.0135.0030.4833.396.29M+8.83%
2026-06-2930.7731.1630.1930.681.27M-0.29%
2026-06-2629.3930.9929.3730.770+5.20%
2026-06-2529.5130.5729.0729.251.91M+0.48%
2026-06-2429.0230.1429.0129.111.64M+1.22%
2026-06-2329.0929.3928.5028.761.86M-0.93%
2026-06-2227.8429.3527.7029.032.01M+5.79%
2026-06-1827.5428.1827.3127.443.28M+1.97%
2026-06-1725.0927.9025.0926.913.12M+8.29%
2026-06-1625.5425.6624.5424.852.67M-2.09%
2026-06-1524.6225.3824.5125.381.31M+4.23%
2026-06-1224.0824.7824.0024.351.85M+1.54%
2026-06-1122.9324.0722.4823.981.33M+4.40%
2026-06-1022.5123.2322.4322.971.19M+0.79%
2026-06-0922.1423.0522.0322.791.56M+5.56%
2026-06-0822.2022.2921.3921.591.66M-1.46%
2026-06-0523.0723.4121.7421.911.09M-6.01%
2026-06-0422.5123.4722.1823.311.04M+3.97%
2026-06-0321.8522.5921.8022.421.77M+2.94%
2026-06-0222.4922.6421.3321.781.66M-4.68%
2026-06-0123.6223.8022.6222.851.78M-4.55%
2026-05-2923.5324.0723.3023.941.78M+2.92%
2026-05-2823.4123.9022.7423.261.24M-0.56%
2026-05-2723.1323.5523.0023.391.47M+1.08%
2026-05-2623.6223.7523.0123.141.19M-1.07%
2026-05-2223.6823.6823.3823.391.09M-1.35%
2026-05-2123.2224.1223.1923.711.24M+1.45%
2026-05-2022.5523.5922.5523.371.51M+4.10%
2026-05-1924.0824.0822.2322.452.09M-7.19%
2026-05-1825.1225.1723.9824.191.46M-3.24%
2026-05-1525.7125.9524.8425.001.49M-3.10%
2026-05-1426.6726.6725.7725.801.11M-2.49%
2026-05-1326.6126.9426.2126.461.09M-1.42%
2026-05-1226.3826.8726.0826.841.13M+2.05%
2026-05-1126.4327.4026.2126.301.49M+0.69%
2026-05-0826.2326.6725.9326.121.46M-0.04%
2026-05-0726.0126.5025.5326.131.83M+0.77%
2026-05-0625.8227.2724.2325.933.42M+3.68%
2026-05-0524.9625.3224.4525.01458K+0.81%
2026-05-0424.6925.3224.4924.811.70M+0.16%
2026-05-0124.9025.1124.3624.771.36M+0.32%
2026-04-3024.5025.0924.1824.691.32M+2.11%
2026-04-2924.1324.7623.7124.181.98M-1.43%
2026-04-2824.3225.1424.2524.531.63M+2.25%
2026-04-2724.2725.0523.7823.991.45M-0.46%
2026-04-2424.4424.4423.6824.101.16M-0.74%
2026-04-2324.6025.1123.9524.281.35M-1.34%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

RARE — Frequently Asked Questions

Quick answers to the most common questions about buying RARE stock.

How has RARE stock performed recently?

RARE declined -14.9% over the past year, below its 5-year annualized CAGR of -18.1%. The stock trades above its 200-day moving average, reflecting the downtrend.

What is RARE's all-time high price?

Ultragenyx Pharmaceutical Inc. reached $179.65 on 2020-12-24. The 52-week high is $42.37. Current 1-year return of -14.9% places the stock further from historical peaks.

Where can I download RARE historical price data?

This page provides RARE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.

448 data points · sampled from 3,125